Cart
sales@molnova.com
3-Phenoxybenzaldehyde
CAS No. 39515-51-0
3-Phenoxybenzaldehyde( —— )
Catalog No. M35820 CAS No. 39515-51-0
3-Phenoxybenzaldehyde is a complement (classical pathway) inhibitor with IC50 of 1388μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Phenoxybenzaldehyde
-
NoteResearch use only, not for human use.
-
Brief Description3-Phenoxybenzaldehyde is a complement (classical pathway) inhibitor with IC50 of 1388μM.
-
Description3-Phenoxybenzaldehyde has weak complement classical pathway inhibition and hemolytic activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetComplement System
-
RecptorComplement System
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number39515-51-0
-
Formula Weight198.22
-
Molecular FormulaC13H10O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (504.49 mM; Ultrasonic )
-
SMILESO=CC1=CC=CC(OC2=CC=CC=C2)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Master HE, et al. Synthesis of low molecular weight compounds with complement inhibition activity. Bioorg Med Chem Lett. 2003 Apr 7;13(7):1249-51.?
molnova catalog
related products
-
LNP023
LNP023 (LNP-023) is a highly potent, reversible, selective inhibitor of factor B (IC50=10 nM).
-
Sutimlimab
Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis.
-
BR103
BR103 is a potent, metabolically stable and highly selective small molecule agonist of complement C3a receptor (C3aR) with EC50 of 22?±?8 ?nM.
